Cargando…
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Although biomarkers are perceived as highly relevant for future clinical practice, few biomarkers reach clinical utility for several reasons. Among them, poor reporting of studies is one of the major problems. To aid improvement, reporting guidelines like REMARK for tumour marker prognostic (TMP) st...
Autores principales: | Sekula, Peggy, Mallett, Susan, Altman, Douglas G., Sauerbrei, Willi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470677/ https://www.ncbi.nlm.nih.gov/pubmed/28614415 http://dx.doi.org/10.1371/journal.pone.0178531 |
Ejemplares similares
-
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
por: Mallett, S, et al.
Publicado: (2010) -
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
por: Altman, Douglas G, et al.
Publicado: (2012) -
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
por: Altman, Douglas G., et al.
Publicado: (2012) -
REporting recommendations for tumour MARKer prognostic studies (REMARK)
por: McShane, L M, et al.
Publicado: (2005) -
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An
Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018)